Scilex Holding Co (SCLX)

Healthcare Pharmaceuticals & Medical Research Pharmaceuticals

Track

Stock chart
Ticker: SCLX Exchange: NAS


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Earnings
 
Value bought

Past 90 days

 
Value sold

Past 90 days

 
Net insiders buying

Past 90 days

 
Trades (buy and sell)

Past 90 days

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-18 2024-12-18 B Purchase

SHAH JAISIM

See Remarks

Executive Director
30,000 +27.4%
0.46
USD 13,800 		30,000 +27.4% 0.46 USD 13,800
2024-10-31 2024-10-31 B Purchase

Ji Henry

Executive Chairperson

Executive Director
8,888 +2.9%
0.94
USD 8,351 		8,888 +2.9% 0.94 USD 8,351
2024-10-29 2024-10-29 B Purchase

SHAH JAISIM

See Remarks

Executive Director
32,000 +41.4%
0.99
USD 31,670 		32,000 +41.4% 0.99 USD 31,670
2024-10-18 2024-10-18 B Purchase

Followwill Dorman

Non-Executive Director
1,000 +76.9%
0.99
USD 990 		1,000 +76.9% 0.99 USD 990
2024-10-18 2024-10-18 B Purchase

Chun Jay

Non-Executive Director
5,000 +4.7%
0.95
USD 4,750 		5,000 +4.7% 0.95 USD 4,750
2024-10-18 2024-10-17 B Purchase

Ji Henry

Executive Chairperson

Executive Director
10,000 +20.0%
0.97
USD 9,710 		10,000 +20.0% 0.97 USD 9,710
2024-10-18 2024-10-17 B Purchase

Wu Yue Alexander

Non-Executive Director
20,000 +400.0%
0.95
USD 18,992 		20,000 +400.0% 0.95 USD 18,992
2024-10-18 2024-10-17 B Purchase

Lemus David

Non-Executive Director
2,000 +inf%
0.90
USD 1,800 		2,000 +inf% 0.90 USD 1,800
2024-10-17 2024-10-16 B Purchase

SHAH JAISIM

See Remarks

Executive Director
30,000 +63.4%
0.99
USD 29,751 		30,000 +63.4% 0.99 USD 29,751
2024-10-17 2024-10-16 B Purchase

Ma Stephen Hoi

Chief Financial Officer

Officer
6,700 +41.5%
0.97
USD 6,499 		6,700 +41.5% 0.97 USD 6,499
2024-05-17 2024-05-17 B Purchase

Ma Stephen Hoi

Chief Financial Officer

Officer
14,140 +inf%
0.88
USD 12,443 		14,140 +inf% 0.88 USD 12,443
2024-05-17 2024-05-17 B Purchase

Ji Henry

Executive Chairperson

Executive Director
50,000 +71428.6%
0.88
USD 43,985 		50,000 +71428.6% 0.88 USD 43,985
2024-05-17 2024-05-17 B Purchase

SHAH JAISIM

See Remarks

Executive Director
56,939 +57.5%
0.92
USD 52,099 		56,939 +57.5% 0.92 USD 52,099
2024-05-17 2024-05-17 B Purchase

Chun Jay

Non-Executive Director
57,500 +127.8%
0.90
USD 51,641 		57,500 +127.8% 0.90 USD 51,641
2024-05-17 2024-05-16 B Purchase

SHAH JAISIM

See Remarks

Executive Director
83,061 +523.0%
0.84
USD 69,846 		83,061 +523.0% 0.84 USD 69,846
2023-09-25 2023-09-21 S Sale

Sorrento Therapeutics, Inc.

Large shareholder
60,068,585
0.00
USD 0 		60,068,585 0.00 USD 0
// ... existing code ... // ... rest of the file ...